Breast Cancer Clinical Trial
Official title:
Lifestyle Factors, Inflammation, and Cognition in Breast Cancer Survivors
Verified date | July 2016 |
Source | Texas State University, San Marcos |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The purpose of this study is to examine the relationship between nutrition, physical activity and brain function in breast cancer survivors.
Status | Completed |
Enrollment | 68 |
Est. completion date | May 2016 |
Est. primary completion date | May 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 30 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Breast cancer survivors must have completed primary treatment (chemotherapy, radiation therapy or both) within past 60 months - age-matched controls must have no previous cancer diagnosis - Female - no history of stroke, heart attack or transient ischemic attack - not currently pregnant; can speak, read, and write English - can attend all testing sessions - not blind or legally blind; nonsmoker - no current use of computer-based brain training games (e.g. Lumosity ®, BrainHQ ®). Exclusion Criteria: - male - < 30 or > 70 years of age - breast cancer survivor > 60 months from last treatment or currently undergoing primary treatment - breast cancer survivor never treated with chemotherapy and/or radiation - previous cancer diagnosis other than breast cancer |
Observational Model: Case Control, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
United States | Texas State University | San Marcos | Texas |
Lead Sponsor | Collaborator |
---|---|
Texas State University, San Marcos |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Medical History | Self-reported medical history | Baseline | No |
Other | Quality of Life | Series of questionnaires assessing various aspects of quality of life including physical and mental health | Baseline | No |
Primary | Cognition | A series of computer-based cognitive tasks will be administered via the NIH Toolbox Cognition Battery | Baseline | No |
Secondary | Physical Activity | Physical activity will be measured by a waist-worn accelerometer | Baseline | No |
Secondary | Diet Quality | Diet will be assessed by completion of the online-administered 2005 Block Food Frequency Questionnaire | Baseline | No |
Secondary | Body Composition (objectively measured) | Body composition will be evaluated by BOD POD assessment | Baseline | No |
Secondary | Inflammatory Markers | A fasted blood sample will be collected for measurement of inflammatory markers | Baseline | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |